Active Pharmaceutical Ingredients (API) Market to Amass $359.45 Billion by 2030 at CAGR 5.85% - Grand View Research, Inc.

SAN FRANCISCO, April 29, 2025 /PRNewswire/ -- The global active pharmaceutical ingredients market size is projected to reach USD 359.45 billion by 2030, and it is expected to exhibit a CAGR of 5.85% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth is largely attributed to advancements in active pharmaceutical Ingredients (API) manufacturing, contract manufacturing organizations (CMOs), and biosimilars.

The prevailing trends suggest the growth of the captive API segment in the wake of investments in solving challenges and fostering new chemical ways for the production of APIs in-house. The strategic move can help reduce costs and contamination risk. Predominantly, artificial intelligence and protein synthesis are likely to expedite growth with greater control over the manufacturing process.

The demand for API has risen on the back of the prevalence of chronic diseases, such as cardiovascular diseases (CVD), diabetes and cancer. To illustrate, according to a study published in the U.S. Pharmacist in 2020 and later reported by the CDC in May 2024, around 47% of adults have at least one of the three risk factors (high blood pressure, high LDL cholesterol and smoking) for cardiovascular disease. An upsurge in CVD has aggravated public health burdens, thereby boosting R&D in APIs.

The COVID-19 pandemic underpinned the active pharmaceutical ingredients market, as leading countries and drug companies produced large quantities of components to meet the demand for the treatment of COVID-19. For instance, the U.S. requested that HCQ be imported from India. The virus also affected Canada's medicine supply system, potentially causing complications for patients.

Read full market research report on Active Pharmaceutical Ingredients (API) Market with TOC - Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Type (Generic, Innovative), By Application, By Region, And Segment Forecasts, 2025 - 2030

Soaring consumption of biopharmaceuticals and investments in drug research and development activities for drug manufacturing have driven the industry growth. Meanwhile, high manufacturing costs and unfavorable drug price control in several countries may challenge stakeholders in the ecosystem.

Asia Pacific is anticipated to witness the fastest CAGR during the forecast period, largely due to investments in emerging economies such as China and India. For instance, China is likely to witness traction for generic and innovative APIs. Besides, leading companies have established their operation in the region to boost their portfolios.

Established and emerging players have furthered their investments in organic and inorganic growth strategies, including mergers & acquisitions, R&D, product launches and innovations. In May 2024, Eli Lilly announced an increase in manufacturing investment to USD 9 billion to enhance API production.

Request a free sample copy or view the report summary: Active Pharmaceutical Ingredients Market Report

Active Pharmaceutical Ingredients Market Report Highlights

• Innovative APIs held the lion's share in 2024 on the back of favorable government policies and robust investments in research and development activities for drug development.
• The captive APIs segment accounted for a notable market share in 2024, mainly attributed to an infusion of funds into new chemical methods for in-house API production.
• The synthetic API segment held the largest revenue share in 2024 in the wake of heightened demand for generic drugs.
• North America contributed the maximum revenue share in 2024 and the trend is likely to continue during the forecast period. The robust forecast is primarily attributed to the increasing prevalence of CVD, research in drug development and rising commercialization of APIs.

Active Pharmaceutical Ingredients Market Segmentation

Grand View Research has segmented the global active pharmaceutical ingredients market based on type of synthesis, type of manufacturer, type, application, type of drug, and region:

Active Pharmaceutical Ingredients Market - Type of Synthesis Outlook (Revenue, USD Billion, 2018 - 2030)

• Biotech 
  • Biotech APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
    • Generic APIs
    • Innovative APIs 
  • Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
    • Monoclonal Antibodies
    • Hormones
    • Cytokines
    • Recombinant Proteins
    • Therapeutic Enzymes
    • Vaccines
    • Blood Factors
• Synthetic 
  • Synthetic APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
    • Generic APIs
    • Innovative APIs

Active Pharmaceutical Ingredients Market - Type of Manufacturer Outlook (Revenue, USD Billion, 2018 - 2030)

• Captive APIs
• Merchant APIs

Active Pharmaceutical Ingredients Market - Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Generic APIs
• Innovative APIs

Active Pharmaceutical Ingredients Market - Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Cardiovascular Diseases
• Oncology
• CNS and Neurology
• Orthopedic
• Endocrinology
• Pulmonology
• Gastroenterology
• Nephrology
• Ophthalmology
• Others

Active Pharmaceutical Ingredients Market - Type of Drug Outlook (Revenue, USD Billion, 2018 - 2030)

• Prescription
• OTC

Active Pharmaceutical Ingredients Market - Regional Outlook (Revenue, USD Billion, 2018- 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

List of Key Players in the Active Pharmaceutical Ingredients Market

• Dr. Reddy's Laboratories Ltd.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Cipla Inc.
• AbbVie Inc.
• Aurobindo Pharma
• Sandoz International GmbH (Novartis AG)
• Viatris Inc.
• Fresenius Kabi AG
• STADA Arzneimittel AG

Check out more related studies published by Grand View Research:

• High Potency Active Pharmaceutical Ingredients Market - The global high potency active pharmaceutical ingredients market size is expected to reach USD 40.66 billion by 2030 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the HPAPI market is attributed to rising incidence of cancer, growing targeted therapies, and increasing application of high potency active pharmaceutical ingredients (HPAPI) in treating target diseases. Rising prevalence of cancer is expected to be a major factor.
• Europe Active Pharmaceutical Ingredients (API) Market - The Europe active pharmaceutical ingredients (API) market size is expected to reach USD 66.7 billion by 2030, expanding at a CAGR of 5.75% from 2023 to 2030, according to a new report by Grand View Research, Inc. The development of the biopharmaceutical industry in the region, the rising elderly population, and improvements in the ease of production of complex active pharmaceutical ingredients (API) are some of the market's key drivers.
• U.S. Active Pharmaceutical Ingredients Market - The U.S. active pharmaceutical ingredients market size is expected to reach USD 114.9 billion by 2030 and is projected to grow at a CAGR of 4.7% from 2024 to 2030. This growth is attributed to the increasing demand for innovative medicines, advancements in biotechnology, and the shift towards microbial-based fermentation approaches. In addition, the rising need for environmentally friendly production methods and the rising consciousness of the ecological risks associated with traditional chemical routes have led to a significant rise in the demand for APIs.

Browse Horizon Databook on Active Pharmaceutical Ingredients Market - Global Active Pharmaceutical Ingredients Market Size & Outlook

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research. Gain insights from 30K+ Global & Regional Reports, 120K+ Country Reports, 1.2M+ Market Statistics, 200K+ Company Profiles, and 5 business solutions encompassing ESG and Sustainability Consulting, Procurement Intelligence, Pricing Index and Analysis, and Consumer Analytics.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/active-pharmaceutical-ingredients-api-market-to-amass-359-45-billion-by-2030-at-cagr-5-85---grand-view-research-inc-302441121.html